Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

32 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Implementation of a centralized HPV-based cervical cancer screening programme in Tuscany: First round results and comparison with the foregoing Pap-based screening programme.
Carozzi F, Burroni E, Confortini M, Pompeo G, Bisanzi S, Cellai F, Paganini I, Mantellini P, Iossa A, Lelli L, Di Pierro C, Matucci M, Cannistrà S, Rosati R, Mongia A, Visioli CB, Gorini G, Sani C, The Tuscany Hpv-Based Screening Working Group. Carozzi F, et al. Among authors: di pierro c. J Med Screen. 2022 Jun;29(2):110-122. doi: 10.1177/09691413211067922. Epub 2022 Jan 17. J Med Screen. 2022. PMID: 35038279
Human papillomavirus prevalence in paired urine and cervical samples in women invited for cervical cancer screening.
Burroni E, Bonanni P, Sani C, Lastrucci V, Carozzi F; Hpv ScreeVacc Working Group; Iossa A, Andersson KL, Brandigi L, Di Pierro C, Confortini M, Levi M, Boccalini S, Indiani L, Sala A, Tanini T, Bechini A, Azzari C. Burroni E, et al. Among authors: di pierro c. J Med Virol. 2015 Mar;87(3):508-15. doi: 10.1002/jmv.24085. Epub 2014 Nov 21. J Med Virol. 2015. PMID: 25418873
Determinants of p16/Ki-67 adequacy and positivity in HPV-positive women from a screening population.
Benevolo M, Mancuso P, Allia E, Gustinucci D, Bulletti S, Cesarini E, Carozzi FM, Confortini M, Bisanzi S, Rubino T, Rollo F, Marchi N, Farruggio A, Pusiol T, Venturelli F, Giorgi Rossi P; New Technologies for Cervical Cancer 2 (NTCC2) Working Group. Benevolo M, et al. Cancer Cytopathol. 2021 May;129(5):383-393. doi: 10.1002/cncy.22385. Epub 2020 Nov 3. Cancer Cytopathol. 2021. PMID: 33142029 Free article.
The effect of self-sampled HPV testing on participation to cervical cancer screening in Italy: a randomised controlled trial (ISRCTN96071600).
Giorgi Rossi P, Marsili LM, Camilloni L, Iossa A, Lattanzi A, Sani C, Di Pierro C, Grazzini G, Angeloni C, Capparucci P, Pellegrini A, Schiboni ML, Sperati A, Confortini M, Bellanova C, D'Addetta A, Mania E, Visioli CB, Sereno E, Carozzi F; Self-Sampling Study Working Group. Giorgi Rossi P, et al. Among authors: di pierro c. Br J Cancer. 2011 Jan 18;104(2):248-54. doi: 10.1038/sj.bjc.6606040. Epub 2010 Dec 21. Br J Cancer. 2011. PMID: 21179038 Free PMC article. Clinical Trial.
Comparison of HPV-positive triage strategies combining extended genotyping with cytology or p16/ki67 dual staining in the Italian NTCC2 study.
Benevolo M, Ronco G, Mancuso P, Carozzi F, De Marco L, Allia E, Bisanzi S, Rizzolo R, Gustinucci D, Del Mistro A, Frayle H, Confortini M, Viti J, Iossa A, Cesarini E, Bulletti S, Passamonti B, Gori S, Toniolo L, Bonvicini L, Venturelli F, Wentzensen N, Giorgi Rossi P; NTCC2 Working Group. Benevolo M, et al. EBioMedicine. 2024 Jun;104:105149. doi: 10.1016/j.ebiom.2024.105149. Epub 2024 May 17. EBioMedicine. 2024. PMID: 38759278 Free PMC article.
Estimated acceptance of HPV vaccination among Italian women aged 18-26 years.
Giambi C, Donati S, Declich S, Salmaso S, Ciofi Degli Atti ML, Alibrandi MP, Brezzi S, Carozzi F, Collina N, Franchi D, Lattanzi A, Meda M, Minna MC, Nannini R, Scherillo I, Bella A; PreGio Working Group. Giambi C, et al. Vaccine. 2011 Oct 26;29(46):8373-80. doi: 10.1016/j.vaccine.2011.08.079. Epub 2011 Aug 26. Vaccine. 2011. PMID: 21872630
32 results